Quantitative analysis for AstraZeneca PLC (AZN) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Hold (50.0) (grade C). 41 signals analyzed (35 differentiated alt-data).
AZN stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $187.00 | $181.73 | $185.20 |
| 2026-05-11 | $185.81 | $181.73 | $181.86 |
| 2026-05-21 | $191.50 | $184.98 | $189.75 |
| 2026-06-03 | $177.56 | $174.60 | $176.28 |
| 2026-06-15 | $179.22 | $176.55 | $177.27 |
| 2026-06-26 | $189.57 | $184.38 | $188.41 |
| 2026-07-09 | $180.21 | $172.76 | $178.49 |
| 2026-07-21 | $169.43 | $164.82 | $169.34 |
| 2026-07-31 | $170.72 | $168.44 | $169.64 |
| 2026-08-12 | $159.02 | $157.12 | $158.50 |
| 2026-08-24 | $167.08 | $163.98 | $166.71 |
| 2026-09-03 | $165.74 | $162.24 | $164.77 |
How AstraZeneca PLC stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| NVS | Novartis AG | $287.1B | — |
| NVO | Novo Nordisk A/S | $200.3B | — |
| SNY | Sanofi | $107.6B | — |
| GSK | GSK plc | $102.1B | — |
View all Health Care stocks by valuation and signals →
AstraZeneca PLC (AZN) scores Hold (50.0), and the composite conceals a 55-point disagreement between its dimensions. It is strongest on ML forecast at 70, and weakest on technicals at 15. A stock can carry ML forecast that high while technicals sits at 15; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| ML forecast | 70 |
| analyst consensus | 42 |
| technicals | 15 |
StoQuant analyzes 41 signals (35 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on AstraZeneca PLC (AZN): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/AZN"><img src="https://stoquant.com/badge/AZN.svg" alt="AstraZeneca PLC (AZN) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.